• Rhode Island Lyme Disease Law



    Chapter 04-035 – 2004 — S 2939 -Enacted06/08/04

    A N  A C T

    RELATING TO HEALTH AND SAFETY — LYME DISEASE AND TREATMENT

    Introduced By: Senators Damiani, Polisena, Sosnowski, Breene, and DaPonte

    Date Introduced:February 11, 2004

    It is enacted by the General Assembly as follows:

     

    SECTION 1. Section 5-37.5-5 of the General Laws in Chapter 5-37.5 entitled “Lyme

    Disease Diagnosis and Treatment” is hereby amended to read as follows:

    5-37.5-5. Mandatory coverage for certain Lyme disease treatments. [Effective until

    December 31, 2004.] — Every individual or group hospital or medical expense insurance policy

    or individual or group hospital or medical services plan contract delivered, issued for delivery, or

    renewed in this state on or afterJanuary 1, 2004, shall provide for Lyme disease treatment as

    provided in chapters 27-18, 27-19, 27-20, and 27-41 of the general laws.

    SECTION 2. Section 27-18-62 of the General Laws in Chapter 27-18 entitled “Accident

    and Sickness Insurance Policies” is hereby amended to read as follows:

     

    27-18-62. Mandatory coverage for certain lyme disease treatments. [Effective until

    December 31, 2004.] Every individual or group hospital or medical expense insurance policy

    or individual or group hospital or medical services plan contract delivered, issued for delivery, or

    renewed in this state on or afterJanuary 1, 2004shall provide coverage for diagnostic testing and

    long-term antibiotic treatment of chronic lyme disease when determined to be medically

    necessary and ordered by a physician acting in accordance with chapter 37.5 of title 5 entitled

    “lyme disease diagnosis and treatment” after making a thorough evaluation of the patient’s

    symptoms, diagnostic test results and response to treatment. Treatment otherwise eligible for

    benefits pursuant to this section shall not be denied solely because such treatment may be

    characterized as unproven, experimental, or investigational in nature. Provided, however, this

    section shall not apply to insurance coverage providing benefits for:

     

    (1) Hospital confinement indemnity;

    (2) Disability income;

    (3) Accident only;

    (4) Long-term care;

    (5) Medicare supplement;

    (6) Limited benefit health;

    (7) Specified disease indemnity;

    (8) Sickness or bodily injury or death by accident or both; and

    (9) Other limited benefit policies.

    SECTION 3. Section 27-19-53 of the General Laws in Chapter 27-19 entitled “Nonprofit

    Hospital Service Corporations” is hereby amended to read as follows:

     

    27-19-53. Mandatory coverage for certain lyme disease treatments. [Effective until

    December 31, 2004.] Every individual or group hospital or medical expense insurance policy

    or individual or group hospital or medical services plan contract delivered, issued for delivery, or

    renewed in this state on or afterJanuary 1, 2004shall provide coverage for diagnostic testing and

    long term antibiotic treatment of chronic lyme disease when determined to be medically

    necessary and ordered by a physician acting in accordance with chapter 37.5 of title 5 entitled

    “lyme disease diagnosis and treatment” after making a thorough evaluation of the patient’s

    symptoms, diagnostic test results and response to treatment. Treatment otherwise eligible for

    benefits pursuant to this section shall not be denied solely because such treatment may be

    characterized as unproven, experimental, or investigational in nature.

    SECTION 4. Section 27-20-48 of the General Laws in Chapter 27-20 entitled “Nonprofit

    Medical Service Corporations” is hereby amended to read as follows:

     

    27-20-48. Mandatory coverage for certain lyme disease treatments. [Effective until

    December 31, 2004.] Every individual or group hospital or medical expense insurance policy

    or individual or group hospital or medical services plan contract delivered, issued for delivery, or

    renewed in this state on or afterJanuary 1, 2004shall provide coverage for diagnostic testing and

    long-term antibiotic treatment of chronic lyme disease when determined to be medically

    necessary and ordered by a physician acting in accordance with chapter 37.5 of title 5 entitled

    “lyme disease diagnosis and treatment” after making a thorough evaluation of the patient’s

    symptoms, diagnostic test results and response to treatment. Treatment otherwise eligible for

    benefits pursuant to this section shall not be denied solely because such treatment may be

    characterized as unproven, experimental, or investigational in nature.

    SECTION 5. Section 27-41-65 of the General Laws in Chapter 27-41 entitled “Health

    Maintenance Organizations” is hereby amended to read as follows:

     

    27-41-65. Mandatory coverage for certain lyme disease treatments. [Effective until

    December 31, 2004.] Subscribers to any health maintenance organization plan shall be

    afforded coverage under that plan on or afterJanuary 1, 2004for diagnostic testing and long term

    antibiotic treatment of chronic lyme disease when determined to be medically necessary and

    ordered by a physician acting in accordance with chapter 37.5 of title 5 entitled “lyme disease

    diagnosis and treatment” after making a thorough evaluation of the patient’s symptoms,

    diagnostic test results and response to treatment. Treatment otherwise eligible for benefits

    pursuant to this section shall not be denied solely because such treatment may be characterized as

    unproven, experimental, or investigational in nature.

    SECTION 6. Section 7 of chapter 113 of the Rhode Island Public Laws 2003 is hereby

    amended to read as follows:

     

    Section 7. This act shall take effect upon passage. and shall expire on December 31,

    2004.

    SECTION 7. Section 7 of chapter 114 of the Rhode Island Public Laws 2003 is hereby

    amended to read as follows:

     

    Section 7. This act shall take effect upon passage. and shall expire on December 31,

    2004.

    SECTION 8. This act shall take effect upon passage.